Business Description
Henry Schein Inc
NAICS : 423450
SIC : 5047
ISIN : US8064071025
Share Class Description:
HSIC: Ordinary SharesTotal Employee Number:
25,000Compare
Compare
Traded in other countries / regions
HSIC.USAHS2.GermanyHSIC.Austria0L3C.UKH1SI34.Brazil1HSIC.ItalyHSIC.Mexico Index Membership
S&P 500Russell 1000Russell 3000NASDAQ 100 IPO Date
1995-11-03Description
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.28 | |||||
Debt-to-Equity | 1.21 | |||||
Debt-to-EBITDA | 3.71 | |||||
Interest Coverage | 4.89 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.8 | |||||
Beneish M-Score | -2.54 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.7 | |||||
3-Year EBITDA Growth Rate | 4.7 | |||||
3-Year EPS without NRI Growth Rate | 2.3 | |||||
3-Year FCF Growth Rate | 7.5 | |||||
3-Year Book Growth Rate | 2.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 10.2 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.36 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 30.84 | |||||
9-Day RSI | 40.13 | |||||
14-Day RSI | 46.29 | |||||
3-1 Month Momentum % | 10.12 | |||||
6-1 Month Momentum % | 12.81 | |||||
12-1 Month Momentum % | 30.27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.32 | |||||
Quick Ratio | 0.73 | |||||
Cash Ratio | 0.05 | |||||
Days Inventory | 77.32 | |||||
Days Sales Outstanding | 45.73 | |||||
Days Payable | 41.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 4.2 | |||||
Shareholder Yield % | 2.33 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 31.32 | |||||
Operating Margin % | 5.72 | |||||
Net Margin % | 2.96 | |||||
EBITDA Margin % | 7.55 | |||||
FCF Margin % | 3.77 | |||||
OCF Margin % | 5.15 | |||||
ROE % | 12.23 | |||||
ROA % | 3.6 | |||||
ROIC % | 6.69 | |||||
3-Year ROIIC % | -4.08 | |||||
ROC (Joel Greenblatt) % | 23.47 | |||||
ROCE % | 8.97 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 25.65 | |||||
Forward PE Ratio | 14.63 | |||||
PE Ratio without NRI | 19.95 | |||||
Shiller PE Ratio | 20.99 | |||||
Price-to-Owner-Earnings | 22.16 | |||||
PEG Ratio | 3.38 | |||||
PS Ratio | 0.76 | |||||
PB Ratio | 3.12 | |||||
Price-to-Free-Cash-Flow | 20.25 | |||||
Price-to-Operating-Cash-Flow | 14.82 | |||||
EV-to-EBIT | 21.08 | |||||
EV-to-Forward-EBIT | 13.09 | |||||
EV-to-EBITDA | 14.63 | |||||
EV-to-Forward-EBITDA | 10.75 | |||||
EV-to-Revenue | 1.1 | |||||
EV-to-Forward-Revenue | 0.93 | |||||
EV-to-FCF | 29.29 | |||||
Price-to-GF-Value | 1.02 | |||||
Price-to-Projected-FCF | 1.15 | |||||
Price-to-Median-PS-Value | 0.86 | |||||
Earnings Yield (Greenblatt) % | 4.74 | |||||
FCF Yield % | 5.23 | |||||
Forward Rate of Return (Yacktman) % | 6.14 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HSIC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Henry Schein Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 13,602 | ||
| EPS (TTM) ($) | 3.43 | ||
| Beta | 0.8153 | ||
| 3-Year Sharpe Ratio | 0.17 | ||
| 3-Year Sortino Ratio | 0.26 | ||
| Volatility % | 25.92 | ||
| 14-Day RSI | 46.29 | ||
| 14-Day ATR ($) | 1.790945 | ||
| 20-Day SMA ($) | 89.5595 | ||
| 12-1 Month Momentum % | 30.27 | ||
| 52-Week Range ($) | 61.945 - 92.18 | ||
| Shares Outstanding (Mil) | 111.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Henry Schein Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Henry Schein Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-24 08:00 | In 168 days | ||
| Annual report for 2026 | 2027-02-24 | In 167 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-24 | In 167 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-04 08:00 | In 56 days | ||
| Third quarter earnings results for 2026 | 2026-11-04 | In 55 days | ||
| Baird Global Healthcare Conference | 2026-09-15 12:15 | In 6 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-04 08:00 | 86.51 (+0.19%) | ||
| Second quarter earnings results for 2026 | 2026-08-04 | 86.51 (+0.19%) | ||
| Stifel Jaws & Paws Conference | 2026-05-27 15:00 | 73.90 (-0.47%) | ||
| General meeting for 2026 | 2026-05-21 10:30 | 73.23 (+0.43%) |
Show
Entries
Henry Schein Inc Frequently Asked Questions
What is Henry Schein Inc(HSIC)'s stock price today?
The current price of HSIC is $87.98. The 52 week high of HSIC is $92.18 and 52 week low is $61.95.
When is next earnings date of Henry Schein Inc(HSIC)?
The next earnings date of Henry Schein Inc(HSIC) is 2026-11-04 Est..
Does Henry Schein Inc(HSIC) pay dividends? If so, how much?
Henry Schein Inc(HSIC) does not pay dividend.
Guru Commentaries on NAS:HSIC
Upslope Capital Management
Bullish
2026 Q2
What the manager wrote
Henry Schein is the largest national distributor of dental products and general healthcare supplies. The recent investment from KKR, along with a transition in leadership, is expected to drive efficiency improvements and revenue growth. This positions Henry Schein favorably in the market, as it maintains take-private optionality, which could further enhance its operational capabilities and financial performance.
Upslope+ +2025Q4
Bullish
2025 Q4
Upslope+ +2025Q4+Letter
What the manager wrote
Henry Schein is the leading distributor of dental products in the U.S. and various countries around the world, holding a dominant market share in all major countries. The company has been a slow, steady, and mostly a-cyclical grower. With KKR's strategic stake increasing to 15%, they are actively working with management to enhance shareholder value, focusing on cost controls and accelerated growth in higher margin segments. At just 15x 2026 consensus earnings, HSIC shares appear attractive given their defensive business model and the optionality surrounding KKR's involvement.
Press Release
Articles on Henry Schein Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers